Cito Diagnostics

Cito Diagnostics operates as an integrated service provider in the decentralized diagnostics space, offering hardware, consumables, software, and support to enable testing at the point of care. Their core offering combines CE/IVD-approved PoC devices and rapid tests for parameters like drugs of abuse with a proprietary digital platform that manages user training, test procedure guidance, and result digitization/integration. By handling the entire ecosystem—from medical products to data interfacing—the company aims to reduce complexity, wait times, and costs for its customers, primarily in settings where immediate diagnostic clarity is critical. The business model is service-oriented, generating revenue from the sale and support of its diagnostic solutions.

Integrated point-of-care (PoC) diagnostics ecosystem combining CE/IVD-approved rapid tests and portable analyzers with a proprietary software platform (Lab in App) for user training, procedural guidance, test result digitization, and EHR integration.

Competes in the crowded point-of-care diagnostics market against giants like Abbott, Roche, and Siemens, as well as numerous smaller specialists. Its primary competitive edge is not a single device, but its integrated software and service bundle (Lab in App + DaaS), which aims to reduce the operational burden of decentralized testing for clients.